We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

93 hedge funds and large institutions have $425M invested in Five Prime Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 11

275% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 8

31% more funds holding

Funds holding: 7193 (+22)

15% more capital invested

Capital invested by funds: $369M → $425M (+$56M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
93
Holders Change
+22
Holders Change %
+30.99%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
30
Increased
42
Reduced
11
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RSCM
26
Rock Springs Capital Management
Maryland
$3.11M +$404K +16,000 +13%
SIM
27
Spark Investment Management
New York
$2.88M +$3.18M +126,112 New
BA
28
BlackRock Advisors
Delaware
$2.75M +$356K +14,120 +13%
TCIM
29
TIAA CREF Investment Management
New York
$2.73M +$1.58M +62,654 +110%
Wells Fargo
30
Wells Fargo
California
$2.46M -$571K -22,612 -17%
Prudential Financial
31
Prudential Financial
New Jersey
$2.37M +$1.51M +60,000 +137%
GTC
32
Ghost Tree Capital
New York
$2.29M +$2.52M +100,000 New
AQR Capital Management
33
AQR Capital Management
Connecticut
$2.08M +$2.3M +91,200 New
Citigroup
34
Citigroup
New York
$2.06M +$1.91M +75,767 +530%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.99M +$582K +23,051 +36%
Morgan Stanley
36
Morgan Stanley
New York
$1.76M +$1.77M +70,051 +1,028%
TC
37
TFS Capital
Pennsylvania
$1.51M -$210K -8,334 -11%
BIM
38
BlackRock Investment Management
Delaware
$1.35M +$235K +9,323 +19%
WMSA
39
Weiss Multi-Strategy Advisers
New York
$1.32M -$303K -12,000 -17%
Two Sigma Investments
40
Two Sigma Investments
New York
$1.11M +$1.22M +48,448 New
NFA
41
Nationwide Fund Advisors
Ohio
$1.06M +$298K +11,812 +34%
EI
42
EAM Investors
California
$1.02M +$1.12M +44,488 New
USAA
43
United Services Automobile Association
Texas
$951K +$1.05M +41,600 New
CS
44
Credit Suisse
Switzerland
$932K +$549K +21,753 +114%
BCM
45
Bridgeway Capital Management
Texas
$914K -$732K -29,000 -42%
SGAM
46
Smith Group Asset Management
Texas
$897K +$991K +39,250 New
GCP
47
GSA Capital Partners
United Kingdom
$889K +$982K +38,896 New
RFC
48
Russell Frank Company
Washington
$881K +$973K +38,562 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$850K +$136K +5,400 +17%
Charles Schwab
50
Charles Schwab
California
$761K +$202K +8,000 +32%

FPRX Hedge Fund Activity: Q1 2015 in Review

93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2015, worth a combined $425M — up 15% from $369M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new FPRX positions and 8 closed out — a net gain of 22 holders — while 42 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $24.9M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $28.4M sold.

  • 93 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2015, up from 71 in Q4 2014.
  • Funds reported $425M of Five Prime Therapeutics, Inc. stock for Q1 2015, up 15% quarter-over-quarter.
  • 30 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2015 and 8 closed out, a net change of +22 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2015 was Wellington Management Group, an estimated $24.9M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2015 was TPG Group Holdings (SBS) Advisors, an estimated $28.4M sold.

Based on aggregated 13F filings for Q1 2015.